# Euclises Pharmaceuticals, Inc.: Form D filings

Euclises Pharmaceuticals, Inc., a pharmaceuticals company in St. Louis, MO, filed 5 Form D notices with the SEC between 2012 and 2016. The latest, on December 1, 2016, reports $1.2 million sold of a $2.7 million offering to 5 investors.

Find out what Euclises Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Euclises%20Pharmaceuticals%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Euclises%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Feuclises-pharmaceuticals-inc-1550350)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Euclises%20Pharmaceuticals%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Euclises%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Feuclises-pharmaceuticals-inc-1550350)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Missouri](https://specstream.ai/data/form-d/state/missouri): 379 rows, by operating companies, filed since November 1, 2024, $18.95, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/missouri
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 4320 FOREST PARK AVENUE, SUITE 303, St. Louis, MO, 63108
- Phone: (314) 604-2850
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2011
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(c)
- SEC identifier (CIK): 1550350

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 1, 2016 | Amendment | $2,711,198 | $1,216,913 | $1,494,285 | 5 | Nov 9, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1550350/000155035016000003/0001550350-16-000003-index.htm) |
| Oct 1, 2015 | New notice | $662,603 | $0 | $662,603 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1550350/000155035015000002/0001550350-15-000002-index.htm) |
| Oct 1, 2015 | Amendment | $1,851,250 | $1,851,250 | $0 | 9 | Dec 30, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1550350/000155035015000001/0001550350-15-000001-index.htm) |
| Jan 13, 2014 | New notice | $1,400,000 | $300,000 | $1,100,000 | 1 | Dec 30, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1550350/000155035014000001/0001550350-14-000001-index.htm) |
| May 17, 2012 | New notice | $400,000 | $174,998 | $225,002 | 1 | May 4, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1550350/000155035012000001/0001550350-12-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Charles A. Bolten | Director |  |
| John J. Talley | Director |  |
| Robert J. Calcaterra | Director |  |
| Rajesh J. Devraj | Director |  |
| Rick J. Ryan | Director |  |
| Robert A. Beardsley | Director |  |
| Bobby W. Sandage, Jr. | Executive Officer, Director |  |

## Other pharmaceuticals companies in Missouri that filed recently

- [Immunophotonics, Inc.](https://specstream.ai/data/form-d/company/immunophotonics-inc-1490953) $10.1 million · Sep 4, 2026

[Every Form D from the week of Nov 28, 2016](https://specstream.ai/data/form-d/week/2016-11-28) · [All recent filings in Missouri](https://specstream.ai/data/form-d/state/missouri) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Euclises Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).